WealthCollab’s MediWound MDWD Stock Holding History

WealthCollab’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25	Closed	-$388	–	989
2025 Q1	$388	Buy	+25	New	+$447	﹤0.01%	889

Other funds holding MDWD

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WealthCollab's MDWD Position: Q2 2025 in Review

WealthCollab sold out of MediWound (MDWD) in Q2 2025, closing a stake of 25 shares — an estimated $388 sold.

WealthCollab first reported a position in MDWD in Q1 2025 and held it in 1 quarter. The position peaked at $388 in Q1 2025. 68 funds tracked by Wall St. Rank hold MDWD as of Q2 2025.

WealthCollab reported no remaining MediWound position as of Q2 2025 after selling out during the quarter.
WealthCollab sold 25 MediWound shares in Q2 2025, an estimated $388.
WealthCollab first reported a position in MediWound in Q1 2025 and held it in 1 quarter.
WealthCollab's MediWound position peaked at $388 in Q1 2025.
68 funds tracked by Wall St. Rank held MediWound as of Q2 2025.

Based on WealthCollab's 13F filing for Q2 2025, filed 15 Aug 2025.